Isofol's Board of Directors appoints Roger Tell as acting CEO of the company
Gothenburg, Sweden, June 22, 2023 – Isofol Medical AB (publ) announces today that its Board of Directors has decided to appoint Roger Tell as acting CEO for the company, effective immediately.The information in the press release is intended for investors. Dr. Roger Tell (b. 1965) has been active in Isofol since 2019 and is today responsible for medical and scientific issues. He first held a position as Senior Vice President of Clinical Development and Chief Scientific Officer, thereafter, moving on to a role as Chief Medical Officer. He joined Isofol from Aprea Therapeutics, where he was